BCL2L1

Existing Annotations Review

Gene Description

Existing Annotations Review

Core Functions

References

Deep Research

Falcon

Perplexity

📚 Additional Documentation

Notes

📄 View Raw YAML

GO Term	Evidence	Action	Reason
GO:0043065 positive regulation of apoptotic process	IBA GO_REF:0000033	MARK AS OVER ANNOTATED	Summary: ISOFORM-CONFLATED ANNOTATION. This annotation is misleading when applied to the gene as a whole. The canonical isoform Bcl-xL (Q07817-1) is ANTI-apoptotic, not pro-apoptotic. Only the short isoform Bcl-xS (Q07817-2) promotes apoptosis. The IBA evidence (phylogenetic inference) does not distinguish between isoforms and may reflect Bcl-xS function or misannotation of paralogs in the Bcl-2 family. The original paper PMID:8358789 clearly shows "bcl-xL inhibits cell death" while "bcl-xS encodes a protein that inhibits the ability of bcl-2 to enhance survival." Reason: This annotation conflates the pro-apoptotic function of Bcl-xS with the gene as a whole. The dominant Bcl-xL isoform is anti-apoptotic. If retained, this should be isoform-specific to Q07817-2 (Bcl-xS). The IBA evidence does not provide isoform resolution. Supporting Evidence: PMID:8358789 bcl-xS, encodes a protein that inhibits the ability of bcl-2 to enhance the survival of growth factor-deprived cells file:human/BCL2L1/BCL2L1-deep-research-perplexity.md provider: perplexity file:human/BCL2L1/BCL2L1-deep-research-falcon.md Bcl-xL (long): ~233 aa, anti-apoptotic/pro-survival. ... Bcl-xS (short): ~170 aa, pro-apoptotic.
GO:0097192 extrinsic apoptotic signaling pathway in absence of ligand	IBA GO_REF:0000033	ACCEPT	Summary: Bcl-xL participates in the extrinsic apoptotic signaling pathway, particularly in absence of ligand (growth factor withdrawal). PMID:8358789 demonstrated that Bcl-xL inhibits cell death upon growth factor withdrawal. PMID:7650367 showed that "Stable transfection of either bcl-2 or bcl-x expression plasmids promotes the survival of CTLL-2 cells in the setting of IL-2 withdrawal." This IBA annotation appropriately captures Bcl-xL's role in this pathway, though the term could be more specific about the direction of regulation. Reason: The IBA annotation correctly places BCL2L1 in the extrinsic apoptotic pathway context. The foundational paper PMID:8358789 shows Bcl-xL inhibits cell death upon growth factor withdrawal. However, this is a process annotation rather than a regulatory term, which is acceptable as Bcl-xL is indeed involved in this pathway as an inhibitor. The function is core to Bcl-xL biology. Supporting Evidence: PMID:8358789 bcl-xL inhibits cell death upon growth factor withdrawal at least as well as bcl-2 PMID:7650367 Stable transfection of either bcl-2 or bcl-x expression plasmids promotes the survival of CTLL-2 cells in the setting of IL-2 withdrawal
GO:0005741 mitochondrial outer membrane	IBA GO_REF:0000033	ACCEPT	Summary: Core localization for Bcl-xL. UniProt states "Mitochondrion outer membrane" as a primary location. The deep research confirms "The selective targeting of Bcl-xL to the mitochondrial outer membrane (MOM) is mediated by the positively charged residues flanking its hydrophobic transmembrane domain." The C-terminal transmembrane domain (residues 210-226) functions as a mitochondrial targeting signal. At the MOM, Bcl-xL resides near VDACs and regulates MOMP. Reason: Well-established core localization. The transmembrane domain directs Bcl-xL specifically to the MOM where it performs its anti-apoptotic function by inhibiting BAX/BAK. Multiple structural and cell biology studies confirm this localization. Supporting Evidence: PMID:9843949 Bax-induced mitochondrial changes were inhibited by recombinant Bcl-xL and transgene-derived Bcl-2, antiapoptotic members of the Bcl-2 family file:human/BCL2L1/BCL2L1-deep-research-falcon.md Bcl-xL localizes predominantly to the outer mitochondrial membrane
GO:0008630 intrinsic apoptotic signaling pathway in response to DNA damage	IBA GO_REF:0000033	ACCEPT	Summary: Bcl-xL is involved in the intrinsic apoptotic pathway in response to DNA damage. PMID:16608847 demonstrates that "PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells" in the context of DNA damage (adriamycin treatment). The paper shows "PUMA-dependent apoptosis induced by the DNA-damaging agent adriamycin" is regulated by Bcl-xL. The annotation captures Bcl-xL's role as a negative regulator in this pathway. Reason: Bcl-xL is a key negative regulator of the intrinsic apoptotic pathway triggered by DNA damage. It binds and sequesters pro-apoptotic BH3-only proteins like PUMA that are induced by p53 in response to DNA damage. This is a core function of Bcl-xL. Supporting Evidence: PMID:16608847 PUMA initiates apoptosis in part by dissociating Bax and Bcl-X(L), thereby promoting Bax multimerization and mitochondrial translocation
GO:0015267 channel activity	IBA GO_REF:0000033	MODIFY	Summary: Bcl-xL regulates ion channel activity at mitochondrial membranes. UniProt notes Bcl-xL "blocking the voltage-dependent anion channel (VDAC) by binding to it." The deep research states "Bcl-xL decreases ion leak conductance within the F1F0 ATPase complex" and "Bcl-xL binding to VDAC1 and VDAC3 promotes mitochondrial matrix Ca2+ accumulation." However, this is a regulatory activity on channels, not direct channel activity by Bcl-xL itself. Reason: Bcl-xL regulates channel activity but is not itself a channel. It interacts with VDAC and modulates ion leak through ATP synthase, but these are regulatory functions. A more accurate term would be related to channel regulation rather than direct channel activity. Proposed replacements: regulation of ion channel activity Supporting Evidence: PMID:9843949 Bax-induced mitochondrial changes were inhibited by recombinant Bcl-xL... suggesting a possible regulatory effect of F0F1-ATPase on Bax-induced mitochondrial changes
GO:0001836 release of cytochrome c from mitochondria	IBA GO_REF:0000033	MODIFY	Summary: Bcl-xL NEGATIVELY regulates cytochrome c release. PMID:9843949 shows "Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release" and "Bax-induced mitochondrial changes were inhibited by recombinant Bcl-xL." UniProt states Bcl-xL functions by "preventing the release of the caspase activator, CYC1, from the mitochondrial membrane." This annotation is problematic as written - Bcl-xL is involved in this process but as a NEGATIVE regulator. Reason: The term "release of cytochrome c from mitochondria" implies the protein promotes this release. Bcl-xL actually INHIBITS this release. The correct annotation should be GO:0090201 "negative regulation of release of cytochrome c from mitochondria" which is already annotated elsewhere in the GOA. Proposed replacements: negative regulation of release of cytochrome c from mitochondria Supporting Evidence: PMID:9843949 Bax-induced mitochondrial changes were inhibited by recombinant Bcl-xL and transgene-derived Bcl-2
GO:0055085 transmembrane transport	IEA GO_REF:0000108	MARK AS OVER ANNOTATED	Summary: Automated annotation based on logical inference. Bcl-xL regulates transmembrane transport indirectly through its interactions with VDAC and effects on mitochondrial membrane permeability. However, Bcl-xL is not itself a transporter. This term is overly broad and does not accurately capture the molecular function. Reason: This IEA annotation is too general. Bcl-xL regulates membrane permeability and ion transport indirectly through protein-protein interactions (with VDAC, BAX, BAK), not by directly performing transport activity. The annotation lacks specificity about the actual mechanism.
GO:0005741 mitochondrial outer membrane	IEA GO_REF:0000120	ACCEPT	Summary: IEA annotation for mitochondrial outer membrane localization, which is consistent with the IBA annotation already reviewed. This automated annotation is correct and well-supported by experimental data. The MOM is the primary site of Bcl-xL function. Reason: Duplicate of IBA annotation for the same cellular component. The MOM localization is well-established and core to Bcl-xL function. Multiple evidence types supporting the same annotation is acceptable.
GO:0005743 mitochondrial inner membrane	IEA GO_REF:0000044	ACCEPT	Summary: UniProt notes "Mitochondrion inner membrane" as a localization for Bcl-xL. The deep research states "Bcl-xL protein also localizes to the MIM in hippocampal neurons, where it directly binds to the beta-subunit of the F1F0 ATP synthase." This inner membrane localization is associated with the non-apoptotic metabolic function of Bcl-xL. Reason: Secondary localization supported by evidence. While the MOM is the primary location, Bcl-xL has been detected at the inner membrane where it regulates ATP synthase efficiency. This is a legitimate secondary localization associated with a non-canonical but well-documented function.
GO:0005759 mitochondrial matrix	IEA GO_REF:0000044	KEEP AS NON CORE	Summary: UniProt notes "Mitochondrion matrix" as a localization. The deep research mentions matrix localization "in certain cell types and contexts." This is a minor localization compared to the outer membrane. Reason: The mitochondrial matrix localization is reported but represents a minor fraction of Bcl-xL. The primary functional localization is at the outer membrane. Matrix localization may be context-dependent and is not central to the core anti-apoptotic function.
GO:0005813 centrosome	IEA GO_REF:0000044	KEEP AS NON CORE	Summary: UniProt states "Localizes to the centrosome when phosphorylated at Ser-49." PMID:21840391 shows that "During DNA damage-induced G2 arrest, an important pool of phospho-Bcl-xL(Ser49) accumulates in centrosomes which act as essential decision centers for progression from G2 to mitosis." Reason: Centrosome localization is conditional (requires Ser49 phosphorylation) and related to cell cycle checkpoint function rather than the core anti-apoptotic function. This is a legitimate but non-core localization. Supporting Evidence: PMID:21840391 During DNA damage-induced G2 arrest, an important pool of phospho-Bcl-xL(Ser49) accumulates in centrosomes which act as essential decision centers for progression from G2 to mitosis
GO:0005829 cytosol	IEA GO_REF:0000120	ACCEPT	Summary: UniProt notes "Cytoplasm, cytosol" as a localization. The deep research states "After neuronal stimulation, translocates from cytosol to synaptic vesicle and mitochondrion membrane in a calmodulin-dependent manner." A cytosolic pool of Bcl-xL exists before membrane insertion. Reason: Cytosolic localization is valid. Bcl-xL has a soluble cytosolic form before insertion into membranes, and can translocate between cytosol and membranes in response to stimuli.
GO:0006897 endocytosis	IEA GO_REF:0000043	KEEP AS NON CORE	Summary: UniProt notes that Bcl-xL "regulates endocytic vesicle retrieval in hippocampal neurons through association with DMN1L and stimulation of its GTPase activity in synaptic vesicles." This represents a non-apoptotic neuronal function. Reason: Endocytosis regulation is a specialized neuronal function of Bcl-xL, separate from its core anti-apoptotic role. It involves interaction with Drp1/DMN1L at synaptic vesicles. This is a legitimate but tissue-specific non-core function.
GO:0006915 apoptotic process	IEA GO_REF:0000120	ACCEPT	Summary: Bcl-xL is indeed involved in apoptosis as a NEGATIVE regulator. PMID:8358789 established that "bcl-xL inhibits cell death upon growth factor withdrawal." The term is accurate but very broad - Bcl-xL specifically negatively regulates apoptosis. Reason: BCL2L1 is fundamentally involved in apoptotic process regulation. While this term is broad, it is accurate. The gene is a central regulator of apoptosis and the IEA annotation is appropriate as a high-level annotation.
GO:0006950 response to stress	IEA GO_REF:0000117	MARK AS OVER ANNOTATED	Summary: Bcl-xL is involved in cellular stress responses. PMID:29507230 shows that "Sustained ER stress... increases RNF183 protein levels" which then "interacts with Bcl-xL...and polyubiquitinates Bcl-xL for degradation." Bcl-xL protein levels are regulated in response to various cellular stresses. Reason: This term is extremely broad. While Bcl-xL is regulated by and responds to various stresses, this high-level term does not capture the specific molecular function. More specific terms like those for apoptotic signaling pathways are preferred.
GO:0016020 membrane	IEA GO_REF:0000120	MARK AS OVER ANNOTATED	Summary: Generic membrane annotation. Bcl-xL is indeed a membrane protein with a C-terminal transmembrane domain. However, this is too broad - more specific membrane annotations (mitochondrial outer membrane, ER membrane) are already present. Reason: This term is too general. More specific membrane localization terms (GO:0005741 mitochondrial outer membrane, GO:0005783 endoplasmic reticulum) are already annotated and provide much more informative cellular component information.
GO:0030672 synaptic vesicle membrane	IEA GO_REF:0000044	KEEP AS NON CORE	Summary: UniProt notes "Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane" as a localization. The deep research describes "After neuronal stimulation, translocates from cytosol to synaptic vesicle and mitochondrion membrane in a calmodulin-dependent manner." Reason: Synaptic vesicle localization is specific to neurons and represents a non-apoptotic function of Bcl-xL in regulating synaptic plasticity and vesicle dynamics. This is a legitimate tissue-specific localization but not the core function.
GO:0031410 cytoplasmic vesicle	IEA GO_REF:0000043	MARK AS OVER ANNOTATED	Summary: Generic cytoplasmic vesicle annotation. More specific annotation for synaptic vesicle membrane (GO:0030672) exists and provides better precision. Reason: This term is too general. The more specific synaptic vesicle membrane term already captures the vesicular localization. This broad term adds little information beyond what is already covered by more specific annotations.
GO:0031965 nuclear membrane	IEA GO_REF:0000044	KEEP AS NON CORE	Summary: UniProt notes "Nucleus membrane" as a localization. The nuclear envelope is continuous with the ER, and Bcl-xL's ER localization may extend to the nuclear membrane. Reason: Nuclear membrane localization is likely a secondary location. The primary functional sites are the mitochondrial outer membrane and ER. This annotation is acceptable but represents a minor localization.
GO:0042981 regulation of apoptotic process	IEA GO_REF:0000002	ACCEPT	Summary: Core function. Bcl-xL is a central regulator of apoptosis. PMID:8358789 describes it as "a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death." This term is accurate though the more specific "negative regulation of apoptotic process" (GO:0043066) would be preferred for Bcl-xL specifically. Reason: Accurate annotation capturing the core regulatory function. While "negative regulation" would be more precise for Bcl-xL, this general regulatory term is still appropriate given that the BCL2L1 locus produces both anti-apoptotic (Bcl-xL) and pro-apoptotic (Bcl-xS) isoforms.
GO:0043066 negative regulation of apoptotic process	IEA GO_REF:0000117	ACCEPT	Summary: CORE FUNCTION of Bcl-xL isoform. PMID:8358789 established that "bcl-xL inhibits cell death upon growth factor withdrawal at least as well as bcl-2." PMID:9843949 showed "Bax-induced mitochondrial changes were inhibited by recombinant Bcl-xL." This is the primary molecular function of the canonical Bcl-xL isoform. Reason: This is the most accurate and specific annotation for the core function of Bcl-xL. The anti-apoptotic activity is mediated through sequestration of pro-apoptotic BH3-only proteins and direct inhibition of BAX/BAK oligomerization. Supporting Evidence: PMID:8358789 bcl-xL inhibits cell death upon growth factor withdrawal at least as well as bcl-2 PMID:9843949 Bax-induced mitochondrial changes were inhibited by recombinant Bcl-xL file:human/BCL2L1/BCL2L1-deep-research-falcon.md The primary function of Bcl-xL is to prevent mitochondrial outer membrane permeabilization (MOMP) by inhibiting BAX activity and/or sequestering BH3-only proteins, thereby blocking cytochrome c release and downstream caspase activation.
GO:0051707 response to other organism	IEA GO_REF:0000117	MARK AS OVER ANNOTATED	Summary: PMID:17428862 shows SARS-CoV 7a protein "interacts with Bcl-XL" and "triggers apoptosis by interfering directly with the prosurvival function of Bcl-XL." Bcl-xL is targeted by viral proteins as part of host-pathogen interactions. However, this is a response where Bcl-xL is a target, not an active responder. Reason: This annotation is too indirect. Bcl-xL is targeted by pathogens (e.g., SARS-CoV 7a) but does not itself "respond" to organisms. The annotation conflates being a target with being a response mechanism.
GO:0097136 Bcl-2 family protein complex	IEA GO_REF:0000117	ACCEPT	Summary: Core cellular component. Bcl-xL forms heterodimers with pro-apoptotic Bcl-2 family members. PMID:9388232 describes "the interactions of BAD with wild type and mutant BCL-2 and BCL-XL proteins" and demonstrates "human Bad interacted with BCL-2 and BCL-XL." Bcl-xL binds BAX, BAK, BAD, BIM, and other BH3-only proteins. Reason: Accurate annotation. Bcl-xL functions by forming complexes with other Bcl-2 family proteins. This complex formation is central to its molecular mechanism of action in regulating apoptosis. Supporting Evidence: PMID:9388232 human Bad interacted with BCL-2 and BCL-XL
GO:1902531 regulation of intracellular signal transduction	IEA GO_REF:0000117	MARK AS OVER ANNOTATED	Summary: Broad term. Bcl-xL does regulate signaling by controlling apoptotic signal transduction. It prevents caspase activation and cytochrome c release which are key signaling events. Reason: This term is too broad and non-specific. More precise annotations about apoptotic signaling pathway regulation are already present and provide better information about the actual function.
GO:2001233 regulation of apoptotic signaling pathway	IEA GO_REF:0000117	ACCEPT	Summary: Core function. Bcl-xL regulates apoptotic signaling through its interactions with pro-apoptotic proteins. This is an appropriate level of annotation though more specific terms exist. Reason: Accurate and appropriately specific annotation for Bcl-xL function. While "negative regulation of apoptotic signaling pathway" would be more precise for Bcl-xL, this term is acceptable as a parent term.
GO:0005515 protein binding	IPI PMID:10446169 Interaction of Alzheimer's presenilin-1 and presenilin-2 wit...	MODIFY	Summary: Generic protein binding annotation. Bcl-xL binds many proteins including BAX, BAK, BAD, BIM, PUMA, VDAC, ATP synthase beta subunit, and others. These interactions should be captured by more specific MF terms. Reason: Per curation guidelines, "protein binding" is uninformative. Bcl-xL's binding function should be annotated with more specific terms like GO:0051434 "BH3 domain binding" which captures its functional binding to pro-apoptotic BH3-only proteins. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:10446169 Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L).
GO:0005515 protein binding	IPI PMID:11583631 BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventi...	MODIFY	Summary: Generic protein binding annotation from high-throughput study. Reason: Per curation guidelines, "protein binding" is uninformative. Should be replaced with specific binding activity terms. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:11583631 BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.
GO:0005515 protein binding	IPI PMID:12815463 HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-x...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:12815463 HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death.
GO:0005515 protein binding	IPI PMID:14739602 The Siva-1 putative amphipathic helical region (SAH) is suff...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:14739602 The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
GO:0005515 protein binding	IPI PMID:16189514 Towards a proteome-scale map of the human protein-protein in...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:16189514 Towards a proteome-scale map of the human protein-protein interaction network.
GO:0005515 protein binding	IPI PMID:16697956 Mitochondria primed by death signals determine cellular addi...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:16697956 Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.
GO:0005515 protein binding	IPI PMID:17418785 Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activati...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:17418785 Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1.
GO:0005515 protein binding	IPI PMID:17525735 ERK1/2-dependent phosphorylation of BimEL promotes its rapid...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:17525735 May 24. ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.
GO:0005515 protein binding	IPI PMID:19060904 An empirical framework for binary interactome mapping.	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:19060904 An empirical framework for binary interactome mapping.
GO:0005515 protein binding	IPI PMID:19180116 DAP-kinase-mediated phosphorylation on the BH3 domain of bec...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:19180116 DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy.
GO:0005515 protein binding	IPI PMID:19427857 Transcriptomic and proteomic approach to studying SNX-2112-i...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:19427857 Epub 2009 May 8. Transcriptomic and proteomic approach to studying SNX-2112-induced K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice.
GO:0005515 protein binding	IPI PMID:21988832 Toward an understanding of the protein interaction network o...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:21988832 Toward an understanding of the protein interaction network of the human liver.
GO:0005515 protein binding	IPI PMID:25241761 Using an in situ proximity ligation assay to systematically ...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:25241761 Oct 9. Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.
GO:0005515 protein binding	IPI PMID:25416956 A proteome-scale map of the human interactome network.	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:25416956 A proteome-scale map of the human interactome network.
GO:0005515 protein binding	IPI PMID:26871637 Widespread Expansion of Protein Interaction Capabilities by ...	MODIFY	Summary: Generic protein binding annotation. Reason: Per curation guidelines, "protein binding" is uninformative. Proposed replacements: BH3 domain binding Supporting Evidence: PMID:26871637 Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.